1. Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers

   • Vassilis Koudas
   • Alexandra Nikolaou
   • Panos Bitsios

   Original Investigation 14 March 2009 Pages: 1 - 9

   

2. Glucose modulates event-related potential components of recollection and familiarity in healthy adolescents

   • Michael A. Smith
   • Leigh M. Riby
   • Jonathan K. Foster

   Original Investigation 10 March 2009 Pages: 11 - 20

   

3. Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors

   • José M. Entrena
   • Enrique J. Cobos
   • Esperanza Del Pozo

   Original Investigation Open access 27 March 2009 Pages: 21 - 33

   

4. Amphetamine pretreatment facilitates appetitive sexual behaviors in the female rat

   • Veronica M. Afonso
   • Devin Mueller
   • James G. Pfaus

   Original Investigation 13 March 2009 Pages: 35 - 43

   

5. The role of cannabis in cognitive functioning of patients with schizophrenia

   • Thomas Schnell
   • Dagmar Koethe
   • Euphrosyne Gouzoulis-Mayfrank

   Original Investigation 27 March 2009 Pages: 45 - 52

6. The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial

   • Anders Hammarberg
   • Nitya Jayaram-Lindström
   • Malcolm S. Reid

   Original Investigation 25 March 2009 Pages: 53 - 62

   

7. An endocannabinoid signal associated with desire for alcohol is suppressed in recently abstinent alcoholics

   • Regina A. Mangieri
   • Kwang-Ik A. Hong
   • Rajita Sinha

   Original Investigation 03 April 2009 Pages: 63 - 72

   

8. Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine

   • J. M. P. Baas
   • N. Mol
   • J. van Gerven

   Original Investigation Open access 05 May 2009 Pages: 73 - 84

   

9. Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers

   • Jamie Horder
   • Philip J. Cowen
   • Catherine J. Harmer

   Original Investigation 01 April 2009 Pages: 85 - 91

   

10. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep–wake cycle architecture

    • Amandine Descamps
    • Colette Rousset
    • Raymond Cespuglio

    Original Investigation 16 April 2009 Pages: 93 - 106

    

11. The impact of age on the hypnotic effects of eszopiclone and zolpidem in the guinea pig

    • Mingchu Xi
    • Michael H. Chase

    Original Investigation Open access 03 April 2009 Pages: 107 - 117

    

12. Amisulpride is a potent 5-HT₇ antagonist: relevance for antidepressant actions in vivo

    • Atheir I. Abbas
    • Peter B. Hedlund
    • Bryan L. Roth

    Original Investigation 01 April 2009 Pages: 119 - 128

    

13. Effects of the MCH1 receptor antagonist SNAP 94847 on high-fat food-reinforced operant responding and reinstatement of food seeking in rats

    • Sunila G. Nair
    • Tristan Adams-Deutsch
    • Yavin Shaham

    Original Investigation 02 April 2009 Pages: 129 - 140

    

14. Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice

    • Ming-Che Ho
    • Chianfang G. Cherng
    • Lung Yu

    Original Investigation 03 April 2009 Pages: 141 - 149

    

15. Effect of aspirin on hypothalamic–pituitary–adrenal function and on neuropsychological performance in healthy adults: a pilot study

    • Stuart Watson
    • Kate Horton
    • I. Nicol Ferrier

    Original Investigation 29 April 2009 Pages: 151 - 155

    

16. A novel touchscreen-automated paired-associate learning (PAL) task sensitive to pharmacological manipulation of the hippocampus: a translational rodent model of cognitive impairments in neurodegenerative disease

    • J. C. Talpos
    • B. D. Winters
    • T. J. Bussey

    Original Investigation 09 April 2009 Pages: 157 - 168

    

17. Lithium treatment in Alzheimer’s disease does not promote cognitive enhancement, but may exert long-term neuroprotective effects

    • Nunzio Pomara

    Letter to the Editors 20 March 2009 Pages: 169 - 170

18. The future of endocannabinoid-oriented clinical research after CB₁ antagonists

    • Bernard Le Foll
    • David A. Gorelick
    • Steven R. Goldberg

    Commentary 20 March 2009 Pages: 171 - 174

19. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep–wake cycle architecture

    • Amandine Descamps
    • Colette Rousset
    • Raymond Cespuglio

    Erratum 05 May 2009 Pages: 175 - 175